Abstract
Advances in medical technology have contributed both to the quality of health care and to its costs. The marketplace doesn't produce sufficient information to anticipate either real health or economic value. Formal assessment of new technologies for safety, efficacy, effectiveness, and cost has been unimpressively dominated by government. While new agency and institutional arrangements promise greater success, they will require a balance between public and private sector roles in procedures and financial support.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
